Biospecimen Collection
OtherBlood collection at baseline and time of surgery
NCT Number: NCT06780176
The purpose of this study is to understand why different people have different risks and outcomes for breast cancer and non-breast cancer.
Interested in participating?
Request Info18 year and older
All sexes
Observational
University of California, Los Angeles (Specimen Analysis only), Los Angeles, California, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Blood collection at baseline and time of surgery
Tissue collection will be attempted at time of surgery
Survey collection at baseline, post-surgery, at 1, 3 and 5 year follow up visits
Time frame: Up to 5 years
The purpose of this study is to prospectively collect and store clinical data, blood and tissue samples, and participant survey data to evaluate (epi) genomic and non-genomic causes of disparity.
Contact information is provided by the study sponsor or research team.
George Plitas, MD
CONTACT
Neha Goel, MD, MPH
CONTACT
Memorial Sloan Kettering Cancer Center
Other
Genomic and Non-Genomic Factors Associated With Breast Cancer Risk Factors and Outcomes in a Diverse South Florida Population
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06335069
Breast Cancer, Breast Diseases
Maastricht, Netherlands
View Trial DetailsNCT06805812
Abemaciclib, Breast Adenocarcinoma
Aviano, Italy
View Trial DetailsNCT07038369
Adnexal Diseases, Advanced Solid Tumors
Los Angeles, California, United States
View Trial DetailsNCT04711109
BRCA1 Mutation, Breast Cancer
Los Angeles, California, United States
View Trial Details